Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2017 1
2018 1
2019 4
2020 1
2021 1
2022 1
2023 1
2024 1
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study.
Oliveira LJC, Rosa DD, Katz A, Assad-Suzuki D, Argolo D, Sanches SM, Testa L, Bines J, Kaliks RA, de Melo Gagliato D, Barroso-Sousa R, Corrêa TS, Shimada AK, Dos Anjos CH, Linck R, Megid TBC, Batista DN, Gomes DM, Cesca MG, Gaudêncio D, Moura LMA, Pereira de Araújo JA, Bonadio RC, Silva de Souza Z, Beal JR, Lopes MM, Sales LT, Parisi Marlière JLF, Mano MS. Oliveira LJC, et al. Among authors: shimada ak. Breast. 2025 Oct;83:104554. doi: 10.1016/j.breast.2025.104554. Epub 2025 Aug 5. Breast. 2025. PMID: 40768821 Free PMC article.
Bevacizumab-associated osteonecrosis of the femur and tibia.
Oliveira LJC, Canedo FSNA, Sacardo KP, Alessi JVM, Barbosa FG, Shimada AK, Katz A. Oliveira LJC, et al. Among authors: shimada ak. Oxf Med Case Reports. 2019 May 31;2019(5):omz040. doi: 10.1093/omcr/omz040. eCollection 2019 May. Oxf Med Case Reports. 2019. PMID: 31198576 Free PMC article.
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.
Oliveira LJC, Megid TBC, Rosa DD, Magliano CADS, Assad DX, Argolo DF, Sanches SM, Testa L, Bines J, Kaliks R, Caleffi M, de Melo Gagliato D, Sahade M, Barroso-Sousa R, Corrêa TS, Shimada AK, Batista DN, Musse Gomes D, Cesca MG, Gaudêncio D, Moura LMA, de Araújo JAP, Katz A, Mano MS. Oliveira LJC, et al. Among authors: shimada ak. Ther Adv Med Oncol. 2022 Dec 26;14:17588359221141760. doi: 10.1177/17588359221141760. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36601632 Free PMC article.
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil.
Queiroz MM, Sacardo KP, Ribeiro MF, Gadotti LL, Saddi R, Oliveira LJC, Linck RDM, Cruz MRS, Barroso-Sousa R, Sahade M, Correa TS, Mano MS, Suzuki DA, Shimada AK, Katz A. Queiroz MM, et al. Among authors: shimada ak. Cancer Treat Res Commun. 2023;35:100683. doi: 10.1016/j.ctarc.2023.100683. Epub 2023 Jan 19. Cancer Treat Res Commun. 2023. PMID: 36716534 Free article.
Employment Status Among Brazilian Women With Estrogen Receptor-Positive Nonmetastatic Breast Cancer.
Assad-Suzuki D, Landeiro LCG, Laperche-Santos D, Resende H, Moura FC, Oliveira SCS, Shimada AK, Arakelian R, Galvão ALZ, de Souza BSW, Custódio AGC, de Andrade MCFM, Cardoso Rodrigues Beckedorff Bittencourt Y, Magalhães MCF, Souza CP, Paiva CE, Signorini PA, Carvalho AV, Pereira DJ, Albaneze LC, Nogueira-Rodrigues A, Rosa DD, Barroso-Sousa R. Assad-Suzuki D, et al. Among authors: shimada ak. Cancer Med. 2025 Nov;14(21):e71306. doi: 10.1002/cam4.71306. Cancer Med. 2025. PMID: 41163381 Free PMC article.
17 results